UY25222A1 - Polimorfos de dofetilida - Google Patents

Polimorfos de dofetilida

Info

Publication number
UY25222A1
UY25222A1 UY25222A UY25222A UY25222A1 UY 25222 A1 UY25222 A1 UY 25222A1 UY 25222 A UY25222 A UY 25222A UY 25222 A UY25222 A UY 25222A UY 25222 A1 UY25222 A1 UY 25222A1
Authority
UY
Uruguay
Prior art keywords
dofetilide
polymorphes
polymorphs
methanesulfonamido
methylethylamino
Prior art date
Application number
UY25222A
Other languages
English (en)
Inventor
Gary Nichols
Trevor Jack Newbury
Ian Colin Apleby
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY25222(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Priority to UY25341A priority Critical patent/UY25341A1/es
Publication of UY25222A1 publication Critical patent/UY25222A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La invención se refiere a los polimorfos de dofetilida P162, P162a y P143 prácticamente puros y a las composiciones que los contienen y los usos de tales polimorfos. La dofetilida (fig. 1); N-[4-(2-[2-[4-(metanosulfonamido)fenoxi]-N'-metiletilamino]etil)fenil]metanosulfonamida, es un agente antiarrítmico.
UY25222A 1997-10-27 1998-10-26 Polimorfos de dofetilida UY25222A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY25341A UY25341A1 (es) 1997-10-27 1999-01-08 Procedimiento para la preparacion de polimorfos de dofetilida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (1)

Publication Number Publication Date
UY25222A1 true UY25222A1 (es) 2000-12-29

Family

ID=10821150

Family Applications (2)

Application Number Title Priority Date Filing Date
UY25222A UY25222A1 (es) 1997-10-27 1998-10-26 Polimorfos de dofetilida
UY25341A UY25341A1 (es) 1997-10-27 1999-01-08 Procedimiento para la preparacion de polimorfos de dofetilida

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY25341A UY25341A1 (es) 1997-10-27 1999-01-08 Procedimiento para la preparacion de polimorfos de dofetilida

Country Status (47)

Country Link
US (1) US6124363A (es)
EP (1) EP1027329B1 (es)
JP (1) JP3569495B2 (es)
KR (1) KR100366167B1 (es)
CN (1) CN1146537C (es)
AP (1) AP906A (es)
AR (1) AR015193A1 (es)
AT (1) ATE232199T1 (es)
AU (1) AU737668B2 (es)
BG (1) BG64125B1 (es)
BR (1) BR9813308A (es)
CA (1) CA2307121C (es)
CO (1) CO4970768A1 (es)
DE (1) DE69811256T2 (es)
DK (1) DK1027329T3 (es)
DZ (1) DZ2632A1 (es)
EA (1) EA002656B1 (es)
ES (1) ES2190620T3 (es)
GB (1) GB9722662D0 (es)
GT (1) GT199800165A (es)
HK (1) HK1033933A1 (es)
HN (1) HN1998000165A (es)
HR (1) HRP20000247B1 (es)
HU (1) HUP0004735A3 (es)
ID (1) ID24658A (es)
IL (1) IL135435A0 (es)
IS (1) IS2179B (es)
MA (1) MA24683A1 (es)
MY (1) MY123352A (es)
NO (1) NO325630B1 (es)
NZ (1) NZ503785A (es)
OA (1) OA11350A (es)
PA (1) PA8462001A1 (es)
PE (1) PE122199A1 (es)
PL (1) PL197379B1 (es)
PT (1) PT1027329E (es)
SA (1) SA98190834B1 (es)
SI (1) SI1027329T1 (es)
SK (1) SK5862000A3 (es)
TN (1) TNSN98193A1 (es)
TR (1) TR200001135T2 (es)
TW (1) TW449589B (es)
UA (1) UA67755C2 (es)
UY (2) UY25222A1 (es)
WO (1) WO1999021829A1 (es)
YU (1) YU24000A (es)
ZA (1) ZA989719B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ2017772A3 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
WO1999021829A1 (en) 1999-05-06
CO4970768A1 (es) 2000-11-07
JP2001521023A (ja) 2001-11-06
ATE232199T1 (de) 2003-02-15
HN1998000165A (es) 1999-02-09
BR9813308A (pt) 2000-08-22
PL340805A1 (en) 2001-02-26
MY123352A (en) 2006-05-31
EA200000365A1 (ru) 2000-12-25
HUP0004735A2 (hu) 2001-10-28
AU2151299A (en) 1999-05-17
PT1027329E (pt) 2003-04-30
TR200001135T2 (tr) 2000-09-21
AU737668B2 (en) 2001-08-30
NO20002191D0 (no) 2000-04-27
PE122199A1 (es) 1999-12-02
UA67755C2 (uk) 2004-07-15
HRP20000247A2 (en) 2000-10-31
HUP0004735A3 (en) 2001-12-28
DE69811256D1 (de) 2003-03-13
IS5426A (is) 2000-03-31
DK1027329T3 (da) 2003-02-24
NZ503785A (en) 2004-11-26
CN1146537C (zh) 2004-04-21
KR20010031439A (ko) 2001-04-16
GT199800165A (es) 2000-04-19
CA2307121A1 (en) 1999-05-06
UY25341A1 (es) 1999-09-27
DE69811256T2 (de) 2003-09-18
AP9801371A0 (en) 1998-12-31
TNSN98193A1 (fr) 2005-03-15
NO325630B1 (no) 2008-06-30
SA98190834B1 (ar) 2006-08-21
HRP20000247B1 (en) 2002-08-31
ES2190620T3 (es) 2003-08-01
CA2307121C (en) 2006-12-05
EP1027329A1 (en) 2000-08-16
AP906A (en) 2000-11-30
ID24658A (id) 2000-07-27
MA24683A1 (fr) 1999-07-01
CN1278246A (zh) 2000-12-27
EP1027329B1 (en) 2003-02-05
US6124363A (en) 2000-09-26
KR100366167B1 (ko) 2003-01-09
DZ2632A1 (fr) 2003-03-08
GB9722662D0 (en) 1997-12-24
PA8462001A1 (es) 2000-05-24
SK5862000A3 (en) 2001-10-08
PL197379B1 (pl) 2008-03-31
BG104373A (en) 2000-12-29
IL135435A0 (en) 2001-05-20
YU24000A (sh) 2003-02-28
AR015193A1 (es) 2001-04-18
NO20002191L (no) 2000-04-27
TW449589B (en) 2001-08-11
OA11350A (en) 2003-12-17
EA002656B1 (ru) 2002-08-29
BG64125B1 (bg) 2004-01-30
JP3569495B2 (ja) 2004-09-22
SI1027329T1 (en) 2003-04-30
ZA989719B (en) 2000-04-26
HK1033933A1 (en) 2001-10-05
IS2179B (is) 2006-12-15

Similar Documents

Publication Publication Date Title
MX161554A (es) Composicion acondicionadora para el cabello mejorada
DE69206093T2 (de) Kosmetisches Mittel.
SE8300308L (sv) Nya 3-keto- 4,9,19-nor-stereoider, deras framstellning, deras anvendning som lekemedel, kompositioner innehallande dem och deras nya erhallna mellanprodukter
ES8802037A1 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES2133769T3 (es) Procedimiento para la sintesis diastereoselectiva de analogos de nucleosidos.
DK526489D0 (da) Bademiddel
FR2599246B1 (fr) Orthese dynamique du genou.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
NO952207L (no) Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel
UY25222A1 (es) Polimorfos de dofetilida
BE896274A (fr) Nouvelle utilisation d'analogues de prostaglandines
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
FR2368271A1 (fr) Utilisation de 4-isopropyl-5,5-dimethyl-1,3-dioxannes comme matieres aromatiques et compositions de parfums en contenant
CO4230037A1 (es) Composicion para aplicacion topica a la piel y/o cabello a base de tensioactivo de fosfato y co-tensioactivo
ES540748A0 (es) Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.
BE896818A (fr) Nouvelle utilisation d'analogues des prostaglandines.
DK572187A (da) Fremgangsmaade til kontinuerlig fremstilling af dialkansulfonylperoxid
ATE69607T1 (de) Nematizide mittel.
ES2045155T3 (es) Un metodo para hacer un cosmetico emulsionado para el cabello.
FI893156A (fi) Nya kompositioner av ett primaert limskikt foer en fluoriserad belaeggning baserade pao epoxid- och metakrylharzer, anvaendningen daerav foer belaeggning av metallsubstrat och ett foerfarande foer framstaellning av naemnda belaeggning.
DE3670480D1 (de) Insektizide alkene.
ATE256101T1 (de) Gelbe polymorphe form von 5-amino-2,4,6-triiodo-n,n'-bis(2,3-dihydroxypro yl)-isophthalamid
FR2357243A1 (fr) Utilisation de 2,4-dioxa-spiro(5.5)undecenes-8 comme matieres aromatiques et parfums en renfermant
ATE22005T1 (de) Cremegrundlage.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20181026